Daxxify and Dysport are both botulinum toxin type A. In the United States, both are approved for one cosmetic use only: the frown lines between the eyebrows.
The difference people care about is how long each one lasts. Daxxify is the one marketed on a longer result. That claim comes from its own trials, and it was never measured against Dysport, so the two numbers you see quoted are not measuring the same thing. More on that below.
The doses are not comparable either. Daxxify uses 40 units for frown lines. Dysport uses 50. Neither number can be converted into the other, because each brand uses its own measuring system.
Approved in the US in 2022 — the most recent arrival apart from Letybo.
Approved in the US in 2009, and used in Europe for years before that.
Cervical dystonia is a neck muscle condition. It was added in 2023.
The cosmetic approval is written for adults under 65.
Daxxify uses a small lab-made peptide to hold the toxin steady. It is the only one of the main brands with no human blood protein in it.
It may also contain traces of cow's milk protein.
That is the median time until frown lines stopped being rated none-or-mild. Half the people treated still had none-or-mild lines at 24 weeks, judged by both the doctor and the patient.
Daxxify was launched on the promise of a longer result, and the number attached to it is usually six months.
Here is what that number actually is. In the company's two main trials, half the people treated still had frown lines rated none or mild at about 24 weeks. That is a real finding from a real trial. But it is not the same measurement as Dysport's "up to four months," and the two trials did not enrol the same kind of people or judge the result at the same moments.
Putting the two numbers next to each other looks like a comparison. It is not one. There has never been a trial that gave some people Daxxify and some people Dysport and then measured how long each lasted. Until that exists, anyone telling you Daxxify lasts two months longer than Dysport is doing arithmetic on numbers that do not belong in the same equation.
It is also worth knowing that the longer-duration promise did not carry the product commercially the way its maker expected. Daxxify's price was cut within about a year of launch, and the company was later sold.
Daxxify is the only one of these products that contains no human serum albumin — a protein taken from donated human blood, used in the other brands to keep the toxin stable in the vial.
If that matters to you, it is a real difference and a fair reason to choose. What it is not is evidence that Daxxify is safer or works better. Albumin in the other products has a long safety record, and no study has shown a health advantage to leaving it out.
That last one matters. A small difference between the two sides is common and is usually settled with a few more units once the result has fully set. A clinic that includes that follow-up visit is worth more than one that is slightly cheaper.
Go to an emergency department or call 911. Do not wait for a call back. These are rare, but they are the symptoms named in the FDA boxed warning that every botulinum toxin product carries, deaths have been reported, and they can begin hours or even weeks after treatment.
If a vision change is sudden or severe, seek urgent care rather than waiting.